Results 81 to 90 of about 1,527,893 (148)
Risk Factors for Recurrence of the Anti‐Synthetase Syndrome Related Interstitial Lung Disease
Immunity, Inflammation and Disease, Volume 14, Issue 4, April 2026.ABSTRACT Purpose This current study aimed to detect the risk factors for recurrence of the anti‐synthetase syndrome related interstitial lung disease (ASSD‐ILD). Methods Patients who were diagnosed with ASSD‐ILD and achieved the improving standards after treatment at a single clinical center from January 1, 2017 to January 1, 2022 were retrospectively ...
Zhen‐Yu Ren +4 more
wiley +1 more source
Interstitial lung disease in a patient with antisynthetase syndrome and no myositis
, 2007 Interstitial lung disease in patients with antisynthetase syndrome and no evidence of myositis is rare and may precede other disease manifestations. We report a patient who initially presented with symptoms primarily related to lung involvement.
Tzelepis, George E. +4 more
core +1 more source
A rare case of anti-jo1 syndrome presenting as a interstitial lung disease
Journal of Association of Pulmonologist of Tamil Nadu, 2020 Antisynthetase syndrome is a rare entity and can be missed if not specifically looked in patients whose initial presentation is with Interstitial Lung Disease. Prognosis is altered when patients presenting with Interstitial Lung Disease.
A Kirubanandam +3 more
doaj +1 more source
Intersticial lung disease as the sole manifestation of antisynthetase syndrome
, 2009 The authors report a clinical case of a woman who had a 3 years diagnosis of hipersensitivity pneumonitis based on intersticial lung disease whithout other manifestations.
Machado, P +7 more
core +1 more source
Frontiers in ImmunologyAntisynthetase syndrome (ASS) is a systemic autoimmune disorder classified as a subtype of the idiopathic inflammatory myopathies (IIM). The condition is defined by the presence of mutually exclusive autoantibodies directed against an aminoacyl-tRNA ...
Kun Li +4 more
doaj +1 more source
A case of antisynthetase syndrome in a rheumatoid arthritis patient with anti-PL-12 antibody following treatment with etanercept. [PDF]
, 2011 In our earlier study, we had reported the case of a patient with rheumatoid arthritis (RA), who had anti-Jo-1 antibodies. This patient had received etanercept (ETN) therapy for RA, after which she had developed overt polymyositis (PM).
Tsuneyo Mimori +13 more
core +1 more source
EJ antibody antisynthetase syndrome [PDF]
BMJ Case Reports, 2022 Andrew Robert Benck, Augustine Manadan
openaire +2 more sources
Skeletal Muscle Involvement in Antisynthetase Syndrome
JAMA Neurology, 2017 Antisynthetase syndrome, characterized by myositis, interstitial lung disease, skin rash, arthropathy, and Raynaud phenomenon, is a clinical entity based on the presence of aminoacyl transfer RNA synthetase (ARS) antibodies in patients' serum. However, antisynthetase syndrome is not included in the histological subsets of idiopathic inflammatory ...
Eri, Noguchi +10 more
openaire +3 more sources
Pericarditis as the Initial Manifestation of Antisynthetase Syndrome: A Case Report
Case Reports in RheumatologyAntisynthetase syndrome is a subtype of idiopathic inflammatory myopathy characterized by clinical manifestations that include myositis with a distinctive muscle biopsy pattern. Cardiac involvement has traditionally been considered a rare feature of this
Gianni Lucchetti, Per Sundbom
doaj +1 more source
, 2017 Idiopathic inflammatory myopathies, mainly polymyositis (PM) may occur in the course of several autoimmune diseases. The overlapping forms of myositis, when the patient also meets the criteria for rheumatoid arthritis (RA), affect 3%-5% of myositis ...
Constantin, Tamás +2 more
core +1 more source